Endoscopic criteria and promising biomarkers for serrated adenomas of the colon (literature review)

Colorectal cancer (CRC) is one of the leading causes of death from cancer in many countries of the world, both in men and women, and these rates are on the rise. The probability of suffering from CRC is about 4–5 % and the risk for developing CRC is associated with personal features or habits such as age, chronic disease history and lifestyle, but in most cases colorectal cancer develops as a result of the degeneration of adenomatous formations or along the jagged path. Immune dysregulation, dysbiosis, and epithelial destruction contribute to colorectal cancer carcinogenesis. The gut microbiota has a relevant role, and dysbiosis situations can induce colonic carcinogenesis through a chronic inflammation mechanism. Some of the bacteria responsible for this multiphase process include Fusobacterium spp., Bacteroides fragilis and enteropathogenic Escherichia coli. moreover, CRC is caused by mutations that target oncogenes, tumour suppressor genes and genes related to DNA repair mechanisms.Considering that the average time for the development of adenocarcinoma from precancer takes about 10 years, changes in the microbiota can be a prospective marker for screening precancerous conditions of the colon, as well as the detection of changes in DNA.The work will discuss the relationship between changes in the microbial composition of the colon with the genetic mutations identified by molecular genetic sequencing.

[1]  P. Stanich,et al.  Hereditary or Not? Understanding Serrated Polyposis Syndrome , 2019, Current Treatment Options in Gastroenterology.

[2]  Seth D. Crockett,et al.  Terminology, Molecular Features, Epidemiology, and Management of Serrated Colorectal Neoplasia. , 2019, Gastroenterology.

[3]  Jun Yu,et al.  Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer , 2018, Gut.

[4]  B. Leggett,et al.  CpG Island Methylation in Sessile Serrated Adenomas Increases With Age, Indicating Lower Risk of Malignancy in Young Patients. , 2018, Gastroenterology.

[5]  B. Leggett,et al.  A morphological and molecular study of proposed early forms of traditional serrated adenoma , 2018, Histopathology.

[6]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[7]  Y. Oono,et al.  Superficially serrated adenoma: a proposal for a novel subtype of colorectal serrated lesion , 2018, Modern Pathology.

[8]  B. Leggett,et al.  MLH1–93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAFV600E mutation , 2018, BMC Cancer.

[9]  S. Gallinger,et al.  Lack of evidence for germline RNF43 mutations in patients with serrated polyposis syndrome from a large multinational study , 2016, Gut.

[10]  H. Clevers,et al.  RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation , 2016, Gut.

[11]  T. Frisan.  Bacterial genotoxins: The long journey to the nucleus of mammalian cells. , 2016, Biochimica et biophysica acta.

[12]  I. Nagtegaal,et al.  Clinical risk factors of colorectal cancer in patients with serrated polyposis syndrome: a multicentre cohort analysis , 2015, Gut.

[13]  B. Leggett,et al.  Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma , 2015, Gut.

[14]  J. Cubiella,et al.  Colorectal cancer risk factors in patients with serrated polyposis syndrome: a large multicentre study , 2015, Gut.

[15]  K. Klein,et al.  A clinicopathological and molecular analysis of 200 traditional serrated adenomas , 2015, Modern Pathology.

[16]  G. Trinchieri,et al.  The role of the microbiota in inflammation, carcinogenesis, and cancer therapy , 2015, European journal of immunology.

[17]  F. Chan,et al.  Association between serrated polyps and the risk of synchronous advanced colorectal neoplasia in average‐risk individuals , 2015, Alimentary pharmacology & therapeutics.

[18]  Y. Jeng,et al.  Traditional serrated adenoma has two pathways of neoplastic progression that are distinct from the sessile serrated pathway of colorectal carcinogenesis , 2014, Modern Pathology.

[19]  L. Le,et al.  Germline mutations in oncogene-induced senescence pathways are associated with multiple sessile serrated adenomas. , 2014, Gastroenterology.

[20]  Deepa T. Patil,et al.  Proximal colon cancers and the serrated pathway: a systematic analysis of precursor histology and BRAF mutation status , 2012, Modern Pathology.

[21]  K. Romans,et al.  Serrated polyposis: rapid and relentless development of colorectal neoplasia , 2012, Gut.

[22]  M. Vieth,et al.  Up and downregulation of p16Ink4a expression in BRAF-mutated polyps/adenomas indicates a senescence barrier in the serrated route to colon cancer , 2011, Modern Pathology.

[23]  Hiroaki Ikematsu,et al.  Meshed capillary vessels by use of narrow-band imaging for differential diagnosis of small colorectal polyps. , 2009, Gastrointestinal endoscopy.

[24]  R. Ward,et al.  Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma , 2009, Journal of Clinical Pathology.

[25]  S. Kakar,et al.  Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps , 2008, International journal of cancer.

[26]  A. Ruszkiewicz,et al.  Serrated neoplasia of the colorectum. , 2007, World journal of gastroenterology.

[27]  J. Jass.  Classification of colorectal cancer based on correlation of clinical, morphological and molecular features , 2007, Histopathology.

[28]  Ting Wang,et al.  The gut microbiota as an environmental factor that regulates fat storage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Jass,et al.  Proximal versus distal hyperplastic polyps of the colorectum: different lesions or a biological spectrum? , 2004, Journal of Clinical Pathology.

[30]  Jahn M. Nesland,et al.  Morphologic Reappraisal of Serrated Colorectal Polyps , 2003, The American journal of surgical pathology.

[31]  B. Leggett,et al.  Hyperplastic Polyposis: Association With Colorectal Cancer , 2001, The American journal of surgical pathology.

[32]  C. Fenoglio-Preiser,et al.  Mixed Hyperplastic Adenomatous Polyps/Serrated Adenomas: A Distinct Form of Colorectal Neoplasia , 1990, The American journal of surgical pathology.

[33]  Tsuyoshi Saito,et al.  Distinct WNT/β-catenin signaling activation in the serrated neoplasia pathway and the adenoma-carcinoma sequence of the colorectum , 2015, Modern Pathology.

[34]  Aung Ko Win,et al.  Cancer risks for relatives of patients with serrated polyposis. , 2012, The American journal of gastroenterology.

[35]  M. Redston,et al.  Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplastic-adenoma-carcinoma (serrated) carcinogenic pathway in the colon. , 2005, Human pathology.

[36]  D. L. Sobin,et al.  Histological Typing of Intestinal Tumours , 1989, World Health Organization.

[37]  V. Veselov.  Serrated lesions of the colon , 2022 .